After medical assessment in hospital, patient’s sample of venous blood is taken under supervision of medical staff carrying out the therapy.
The treatment is carried out according to the following scheme:
The therapy is autologous, hence the blood donor and the recipient of the medical product, is one and the same person. The cells are not genetically modified, only the number of Treg cells – naturally low or with lower activity in patients with type 1 diabetes – is multiplied in the laboratory, before the application procedure to the patient.
Therapy is carried out in the University Clinical Centre in “Hospital Exemption Rule” with the full support of hospital facilities together with highest level of purity and in GMP (Good Manufacturing Practice).